SPC343
Túcatíníb, valkvætt á formi lyfjafræðilega viðunandi salts eða lausnarsambands
Status:
VeittApplication date:
6.7.2021Application published:
15.7.2021Grant published:
15.2.2023
Max expiry date:
14.11.2031Next due date:
30.11.2026Medicine name:
TukysaMedicine for children:
No
Timeline
Today
6.7.2021Application
15.7.2021Publication
15.2.2023Registration
14.11.2031Expires
Marketing license
IS authorization number:
EU/1/20/1526/001; EU/1/20/1526/002Date:
19.2.2021
Foreign authorization number:
EU/1/20/1526Date:
11.2.2021
Owner
Name:
Array Biopharma Inc.Address:
3200 Walnut Street, Boulder, CO US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1971601